Question 1

What are the potential benefits of participating in this trial for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients clinical trial (NCT03241550). Contact the study team or your healthcare provider for specific answers.

Question 2

How does isavuconazonium sulfate compare to other antifungal treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients clinical trial (NCT03241550). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should we be aware of during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients clinical trial (NCT03241550). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will we need to visit the clinic for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients clinical trial (NCT03241550). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my child experiences side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients clinical trial (NCT03241550). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options available while we wait for trial results?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients clinical trial (NCT03241550). Contact the study team or your healthcare provider for specific answers.

What this study is about